The downgrade from Overweight to Neutral and the reduction in price target from $182 to $144 by JP Morgan analyst Christopher Horvers indicate a less optimistic outlook for Target's stock. This could lead to a short-term negative impact on the stock price as investors may adjust their positions based on the new rating and price target.